Home » Stocks » ICLR

ICON plc (ICLR)

Stock Price: $180.68 USD -3.76 (-2.04%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Pre-market: $183.23 +2.55 (1.41%) Mar 1, 8:28 AM
Market Cap 9.54B
Revenue (ttm) 2.80B
Net Income (ttm) 332.33M
Shares Out 52.86M
EPS (ttm) 6.15
PE Ratio 29.38
Forward PE 21.88
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $180.68
Previous Close $184.44
Change ($) -3.76
Change (%) -2.04%
Day's Open 185.00
Day's Range 179.54 - 186.62
Day's Volume 1,464,984
52-Week Range 104.28 - 223.62

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 4 days ago

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PR...

Other stocks mentioned: PRAH
Zacks Investment Research - 5 days ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 3.83% and 1.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 5 days ago

DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2020 Results

Business Wire - 5 days ago

DUBLIN--(BUSINESS WIRE)--ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research

Other stocks mentioned: PRAH
Benzinga - 5 days ago

Icon (NASDAQ:ICLR) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.

Zacks Investment Research - 2 weeks ago

Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 3 weeks ago

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announc...

Zacks Investment Research - 3 weeks ago

Icon PLC (ICLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Business Wire - 1 month ago

DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference

Business Wire - 1 month ago

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical de...

Other stocks mentioned: BNTX, PFE
Business Wire - 4 months ago

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference

Seeking Alpha - 4 months ago

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 10.97% and 5.54%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 4 months ago

Shares of Icon (NASDAQ:ICLR) moved lower by 0.6% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 1.15% year over year to $1.72, wh...

Business Wire - 4 months ago

DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical ...

Business Wire - 4 months ago

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device in...

Business Wire - 5 months ago

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device in...

Business Wire - 5 months ago

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference

Business Wire - 6 months ago

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a leading global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industrie...

Seeking Alpha - 7 months ago

ICON's (ICLR) CEO Steven Cutler on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 7 months ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 9.09% and 4.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 7 months ago

Shares of Icon (NASDAQ:ICLR) were unchanged after the company reported Q2 results.

Zacks Investment Research - 7 months ago

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InvestorPlace - 9 months ago

Wayfair stock benefited from the novel coronavirus and is up big year to date. It’s time to consider other stocks.

Other stocks mentioned: STRA, WDAY
Seeking Alpha - 10 months ago

ICON Public Limited Company (ICLR) CEO Dr. Steven Cutler on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Icon PLC (ICLR) delivered earnings and revenue surprises of -1.16% and 0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 11 months ago

This week, we’re highlighting three stocks to buy that have been dragged down by the current market turmoil.

Other stocks mentioned: HD, TJX
Forbes - 11 months ago

These stocks are for great companies whose valuations are a little high. As valuations decline, investors should scoop up these quality businesses.

Other stocks mentioned: HD, TJX
Seeking Alpha - 1 year ago

ICON PLC (ICLR) CEO Steven Cutler on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and -1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Other stocks mentioned: CDNS, CRL, TTC
Zacks Investment Research - 1 year ago

Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Seeking Alpha - 1 year ago

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

Seeking Alpha - 1 year ago

Iconix Brand Group, Inc. (ICON) CEO Bob Galvin on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

Seeking Alpha - 1 year ago

ICON Public Limited Company (ICLR) CEO Steve Cutler on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.60% and 0.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

ICON Public Limited Company (ICLR) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Seeking Alpha - 1 year ago

Icon is a top player in the CRO industry.

Seeking Alpha - 1 year ago

ICON plc (ICLR) CEO Steve Cutler on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) delivered earnings and revenue surprises of 1.88% and 0.52%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

ICLR vs. HQY: Which Stock Is the Better Value Option?

Other stocks mentioned: HQY

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. The company's clinical development services include product development planning, strategic consulting, stud... [Read more...]

Industry
Diagnostics & Research
IPO Date
May 15, 1998
CEO
Stephen Cutler
Employees
16,000
Stock Exchange
NASDAQ
Ticker Symbol
ICLR
Full Company Profile

Financial Performance

In 2020, ICON plc's revenue was $2.80 billion, a decrease of -0.30% compared to the previous year's $2.81 billion. Earnings were $332.33 million, a decrease of -11.14%.

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for ICON plc stock is "Buy." The 12-month stock price forecast is 217.83, which is an increase of 20.56% from the latest price.

Price Target
$217.83
(20.56% upside)
Analyst Consensus: Buy